MedElevator Войти в исследования
← Поиск публикаций

DOI 10.6061/clinics/2020/e1870

Медицинская библиотека · Clinics (Sao Paulo, Brazil) · 2020

Ankylosing spondylitis and psoriatic arthritis: revisiting screening of latent tuberculosis infection and its follow-up during anti-tumor necrosis factor therapy in an endemic area.

Shimabuco Andrea Yukie, Medeiros-Ribeiro Ana Cristina de, Miossi Renata, Bonfiglioli Karina Rossi, Moraes Julio Cesar Bertacini de, Gonçalves Celio Roberto, Sampaio-Barros Percival Degrava, Goldenstein-Schainberg Claudia, Souza Fernando Henrique Carlos de, Prado Leandro Lara do, Ugolini-Lopes Michele Remião, Yuki Emily Figueiredo Vieira Neves, Bonfa Eloisa, Saad Carla Gonçalves Schahin

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

OBJECTIVES

To retrospectively evaluate the performance and distinctive pattern of latent tuberculosis (TB) infection (LTBI) screening and treatment in patients with ankylosing spondylitis (AS) and psoriatic arthritis (PsA) under anti-tumor necrosis factor (TNF) therapy and determine the relevance of re-exposure and other risk factors for TB development.

METHODS

A total of 135 and 83 patients with AS and PsA, respectively, were evaluated for LTBI treatment before receiving anti-TNF drugs via the tuberculin skin test (TST), chest radiography, and TB exposure history assessment. All subjects were evaluated for TB infection at 3-month intervals.

RESULTS

The patients with AS were more often treated for LTBI than were those with PsA (42% versus 30%, p=0.043). The former also presented a higher frequency of TST positivity (93% versus 64%, p=0.002), although they had a lower frequency of exposure history (18% versus 52%, p=0.027) and previous TB (0.7% versus 6%, p=0.03). During follow-up [median, 5.8 years; interquartile range (1QR), 2.2-9.0 years], 11/218 (5%) patients developed active TB (AS, n=7; PsA, n=4). TB re-exposure was the main cause in seven patients (64%) after 12 months of therapy (median, 21.9 months; IQR, 14.2-42.8 months) and five LTBI-negative patients. TB was identified within the first year in four patients (36.3%) (median, 5.3 months; IQR, 1.2-8.8 months), two of whom were LTBI-positive. There was no difference in the TB-free survival according to the anti-TNF drug type/class; neither synthetic drug nor prednisone use was related to TB occurrence (p>0.05).

CONCLUSION

Known re-exposure is the most critical factor for incident TB cases in spondyloarthritis. There are also some distinct features in AS and PsA LTBI screening, considering the higher frequency of LTBI and TST positivities in patients with AS. Annual risk reassessment taking into consideration these peculiar features and including the TST should be recommended for patients in endemic countries.

Для цитирования: Shimabuco Andrea Yukie, Medeiros-Ribeiro Ana Cristina de, Miossi Renata, Bonfiglioli Karina Rossi, Moraes Julio Cesar Bertacini de, Gonçalves Celio Roberto, Sampaio-Barros Percival Degrava, Goldenstein-Schainberg Claudia, Souza Fernando Henrique Carlos de, Prado Leandro Lara do, Ugolini-Lopes Michele Remião, Yuki Emily Figueiredo Vieira Neves, Bonfa Eloisa, Saad Carla Gonçalves Schahin. Ankylosing spondylitis and psoriatic arthritis: revisiting screening of latent tuberculosis infection and its follow-up during anti-tumor necrosis factor therapy in an endemic area.. Clinics (Sao Paulo, Brazil). 2020. DOI: 10.6061/clinics/2020/e1870.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.